Research Report Components and Evidence-Based Writing
May 12, 2026
Study Series 87 research report components, including company overview, business model, competitive position, financial condition, management quality, industry outlook, thesis, valuation, key risks, source support, and plain-language writing.
On this page
A research report is only as strong as the evidence chain behind it. Series 87 expects the analyst to connect the company overview, business model, industry context, financial position, management quality, outlook, thesis, valuation, and risk discussion into one supportable argument.
The exam does not reward promotional writing. It rewards balanced, sourced, internally consistent research that distinguishes facts from assumptions and gives readers enough context to understand why the recommendation could be wrong.
Learning objectives
After this lesson, you should be able to:
explain how research report components and evidence-based writing fit the Series 87 research-control workflow
identify the disclosures, restrictions, approvals, or records that change the answer
recognize when research content, timing, channel, or audience creates a conflict or market-integrity risk
choose the response that keeps research accurate, independent, approved, and retained
What the exam is really testing
Series 87 questions usually test whether research stays inside a controlled pipeline. The fact pattern may involve a report, draft, chart, client call, social post, issuer interaction, or offering context, but the stronger answer asks whether the content is supportable, disclosed, supervised, and distributed fairly. For research report components and evidence-based writing, that means protecting readers from unsupported certainty, hidden conflicts, selective access, and missing records.
Report component
What it should do
Weak answer pattern
Company overview
Describe business model, segments, and revenue drivers accurately
Vague profile with no link to thesis
Competitive position
Use evidence such as share, differentiation, or barriers
Unsupported leadership claims
Financial condition
Explain profitability, cash generation, and leverage at a high level
Cherry-picked metrics with no risk context
Thesis and catalysts
State the core claim and expected path
Opinion without evidence or timing
Valuation
Frame method and assumptions without false precision
Target price detached from assumptions
Risks
Explain what could impair the thesis
Boilerplate risk language unrelated to the recommendation
Control workflow
flowchart TD
A["Research draft"] --> B["Build evidence for business model, financials, industry, and management"]
B --> C["Connect evidence to thesis, catalysts, valuation, and risks"]
C --> D["Separate facts from assumptions and cite key sources"]
D --> E["Check consistency, balance, readability, and disclosure support"]
How to answer fact patterns
Classify the communication: report, draft, update, public appearance, internal summary, or dissemination channel.
Identify the conflict, disclosure, approval, certification, timing, or recordkeeping issue.
Ask whether the proposed action gives any audience unfair, unsupported, or unapproved research access.
Choose the answer that discloses, restricts, escalates, approves, and retains the record before dissemination.
Common exam traps
Writing a bullish thesis without identifying what could prove it wrong.
Using valuation output without explaining key assumptions.
Mixing facts, assumptions, and management claims without labels.
Omitting recent adverse news because it complicates the recommendation.
Using technical language that hides unsupported analysis.
Key concepts
Business model: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Competitive position: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Quality of earnings: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Investment thesis: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Valuation support: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Key risks: know what it changes in disclosure, approval, independence, timing, or dissemination control.
Key takeaways
Series 87 rewards research integrity, not faster distribution.
A short message, chart, call, or public comment can still need the same disclosure and supervision discipline as a formal report.
The safest answer usually protects independence, avoids selective dissemination, and preserves a clear approval and retention record.